Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Gaetano Allegra

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Recenti Progressi in Medicina|August 6, 2019
[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]Vanessa Innao, Alessandro Allegra, Andrea Gaetano Allegra, et al.
Advances in Protein Chemistry and Structural Biology|May 1, 2019
Relationship between mitofusin 2 and cancerAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
International Journal of Molecular Sciences|December 1, 2020
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy EraVanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, et al.
Annals of Hematology|July 17, 2020
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategiesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
European Journal of Cancer Care|January 4, 2020
Therapeutic potential of antagomiRs in haematological and oncological neoplasmsVanessa Innao, Alessandro Allegra, Nicolina Pulvirenti, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy DrugsVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2019
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic MalignanciesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
Cells|March 6, 2021
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple MyelomaVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Antioxidants (Basel, Switzerland)|November 17, 2020
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological MalignanciesAndrea Gaetano Allegra, Federica Mannino, Vanessa Innao, et al.
Cancer Investigation|April 17, 2018
Nanobodies and Cancer: Current Status and New PerspectivesAlessandro Allegra, Vanessa Innao, Demetrio Gerace, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Recenti Progressi in Medicina|August 6, 2019
[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]Vanessa Innao, Alessandro Allegra, Andrea Gaetano Allegra, et al.
Advances in Protein Chemistry and Structural Biology|May 1, 2019
Relationship between mitofusin 2 and cancerAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
International Journal of Molecular Sciences|December 1, 2020
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy EraVanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, et al.
Annals of Hematology|July 17, 2020
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategiesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
European Journal of Cancer Care|January 4, 2020
Therapeutic potential of antagomiRs in haematological and oncological neoplasmsVanessa Innao, Alessandro Allegra, Nicolina Pulvirenti, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy DrugsVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2019
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic MalignanciesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
Cells|March 6, 2021
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple MyelomaVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Antioxidants (Basel, Switzerland)|November 17, 2020
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological MalignanciesAndrea Gaetano Allegra, Federica Mannino, Vanessa Innao, et al.
Cancer Investigation|April 17, 2018
Nanobodies and Cancer: Current Status and New PerspectivesAlessandro Allegra, Vanessa Innao, Demetrio Gerace, et al.
Pageof 4